← All comparisons

GHK-Cu vs BPC-157

Last updated

The key difference

GHK-Cu is a naturally occurring copper-binding tripeptide, studied largely in topical skin and wound-healing research. BPC-157 is a synthetic gastric-derived peptide studied by injection and orally in animal models of tissue injury.

Side by side

What it is
GHK-CuA naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) widely researched for skin regeneration, collagen synthesis, and wound healing. Common in topical cosmetics.
BPC-157A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.
Research status
GHK-CuResearch chemical
BPC-157Research chemical
Category
GHK-CuCollagen & Skin, Tanning & Skin
BPC-157Healing & Recovery
Half-life
GHK-CuShort (minutes) when injected; topical acts locally
BPC-157Approximately 4-6 hours (estimated; rapidly cleared)
Routes
GHK-Cutopical, subcutaneous
BPC-157subcutaneous, intramuscular, oral
Reported dosing
GHK-CuTopical cosmetic research uses ~0.05-2% formulations; injectable research references ~1-2 mg per administration. Educational ranges only.
BPC-157Research literature commonly references 200-500 mcg per administration, once or twice daily, in animal-equivalent and anecdotal human protocols. Not personal medical advice.
Studied for
GHK-Cu
  • Stimulates collagen and elastin synthesis
  • Promotes wound healing and tissue remodeling
  • Antioxidant and anti-inflammatory activity
  • May improve skin firmness, elasticity, and fine lines
BPC-157
  • Accelerated tendon, ligament, and muscle healing in animal models
  • Cytoprotective and ulcer-healing effects on the GI tract
  • Promotes angiogenesis (new blood vessel formation) at injury sites
  • May reduce inflammation in soft tissue and joints
Side effects
GHK-Cu
  • Topical use generally well tolerated; possible irritation or redness
  • Injection-site reactions
  • Theoretical copper accumulation with excessive use
  • Limited human injectable safety data
BPC-157
  • Generally well tolerated in animal studies with low toxicity
  • Possible injection-site irritation, redness, or bruising
  • Occasional reports of mild nausea or fatigue (anecdotal)
  • Long-term human safety data is lacking
Cited studies
GHK-Cu5 on its page
BPC-1574 on its page

How GHK-Cu works

GHK-Cu is a tripeptide that binds copper(II) ions with high affinity and modulates the expression of numerous genes involved in tissue remodeling. It stimulates collagen, elastin, and glycosaminoglycan synthesis by fibroblasts, promotes angiogenesis, and acts as an antioxidant and anti-inflammatory agent. Declining GHK levels with age are associated with reduced regenerative capacity, which underlies its use in skin and wound research.

Full GHK-Cu profile →

How BPC-157 works

BPC-157 is thought to upregulate angiogenesis by promoting VEGFR2 expression and activating the VEGFR2-Akt-eNOS signaling pathway, increasing blood vessel formation at injury sites. It modulates growth-hormone receptor expression in tendon fibroblasts and appears to influence the nitric oxide system. Animal studies also describe protective effects on the gut-brain axis and dopaminergic, serotonergic, and GABAergic systems.

Full BPC-157 profile →

Dosing shown is what research and community sources report, not a recommendation. For educational and research purposes only; not medical advice. How we source this

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.